Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

allogeneic CD34-positive E-rosetted T-cell depleted peripheral blood stem cells

A preparation of CD34+ selected peripheral blood stem cells (PBSCs) that are depleted of T cells via erythrocyte rosetting (E-rosetting) and intended for allogeneic stem cell transplant. Administration of this particular preparation of CD34+E- T-cell depleted PBSCs may potentially reduce the occurrence of graft-versus-host disease (GvHD) without increasing the risk of graft failure or poor graft function.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	allogeneic CD34+E- T-cell depleted PBSCs allogeneic CD34+E- T-cell depleted peripheral blood stem cells

allogeneic CD34-positive E-rosetted T-cell depleted peripheral blood stem cells

Search NCI's Drug Dictionary